Avalo Therapeutics Inc. (AVTX) Revenue and Competitors
Estimated Revenue & Valuation
- Avalo Therapeutics Inc. (AVTX)'s estimated annual revenue is currently $6.4M per year.
- Avalo Therapeutics Inc. (AVTX)'s estimated revenue per employee is $155,000
Employee Data
- Avalo Therapeutics Inc. (AVTX) has 41 Employees.
- Avalo Therapeutics Inc. (AVTX) grew their employee count by 28% last year.
Avalo Therapeutics Inc. (AVTX)'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Legal Officer | Reveal Email/Phone |
2 | Chief Strategy Officer | Reveal Email/Phone |
3 | VP, Clinical Development | Reveal Email/Phone |
4 | SVP, Program Management and Corporate Infrastructure at Avalo Therapeutics, Inc | Reveal Email/Phone |
5 | Head Administration | Reveal Email/Phone |
6 | VP CMC Biologics | Reveal Email/Phone |
7 | VP, Head IT/IS | Reveal Email/Phone |
8 | VP CMC Biologics | Reveal Email/Phone |
9 | Head Administration | Reveal Email/Phone |
10 | VP, Corporate Controller | Reveal Email/Phone |
Avalo Therapeutics Inc. (AVTX) Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Avalo Therapeutics Inc. (AVTX)?
N/A
Total Funding
41
Number of Employees
$6.4M
Revenue (est)
28%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Avalo Therapeutics Inc. (AVTX) News
2022-04-17 - Is Avalo Therapeutics Inc (AVTX) a Stock to Watch After Losing -3.08% This Week?
AVTX receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator. Sentiment Score - ,bearish. Avalo Therapeutics Inc has a...
2022-04-17 - Zacks: Analysts Expect Avalo Therapeutics, Inc. (NASDAQ:AVTX ...
Zacks: Analysts Expect Avalo Therapeutics, Inc. (NASDAQ:AVTX) Will Announce Earnings of -$0.14 Per Share. Posted by admin on Apr 18th, 2022.
2022-04-06 - Should You Buy Avalo Therapeutics Inc (AVTX) Stock on Wednesday?
AVTX gets a Neutral score from InvestorsObserver Stock Sentiment Indicator. Sentiment Score - ,neutral. Avalo Therapeutics Inc has a Neutral...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.3M | 41 | 21% | N/A |
#2 | $3.9M | 41 | -31% | N/A |
#3 | $5.2M | 41 | 24% | N/A |
#4 | $10.5M | 41 | 3% | N/A |
#5 | $7.8M | 41 | 5% | N/A |